Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pyxis Oncology Inc (NQ: PYXS ) 3.785 +0.035 (+0.93%) Streaming Delayed Price Updated: 12:16 PM EDT, Oct 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Pyxis Oncology Inc < Previous 1 2 3 Next > Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer November 28, 2023 Dr. Kobayashi brings over 25 years of experience in oncology drug development, including Antibody Drug Conjugates (ADCs) and other oncology modalities From Pyxis Oncology Via GlobeNewswire Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update November 07, 2023 From Pyxis Oncology Via GlobeNewswire New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review October 13, 2023 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:PYXS),(NASDAQ:AZN),(NYSE:LLY),(NASDAQ:MRUS) EQNX::TICKER_END Via FinancialNewsMedia Exposures Product Safety NASDAQ:PYXS Investor Notice: Investigation over Possible Securities Laws Violations by Pyxis Oncology, Inc. October 05, 2023 San Diego, CA -- (SBWIRE) -- 10/05/2023 -- Pyxis Oncology, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. Via SBWire Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023 September 27, 2023 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology M&A Spotlight Signals Potential Growth Amidst Competitive ADC Landscape: Analyst September 05, 2023 RBC Capital Markets has initiated coverage on Pyxis Oncology Inc (NASDAQ: PYXS) with an Outperform rating and a Via Benzinga Pyxis Oncology to Participate in Two Upcoming Investment Conferences August 31, 2023 From Pyxis Oncology Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023 September 05, 2023 Via Benzinga Pyxis Oncology Successfully Completes Acquisition of Apexigen August 23, 2023 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology Reports Financial Results for Second-Quarter 2023 and Provides Corporate Update August 11, 2023 From Pyxis Oncology Via GlobeNewswire Pyxis Oncology to Present at BTIG Virtual Biotechnology Conference August 01, 2023 From Pyxis Oncology Via GlobeNewswire Small SPAC Biotech Apexigen To Be Acquired Pyxis Oncology For $16M May 24, 2023 Via Benzinga Pyxis Oncology Bolsters Oncology Portfolio Through $16M Apexigen Acquisition May 24, 2023 Pyxis Oncology (NASDAQ:PYXS) has announced an acquisition of Apexigen (NASDAQ:APGN) that is expected to be completed in the second half of 2023. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023 July 31, 2023 Via Benzinga Why Is Apexigen (APGN) Stock Up 31% Today? May 24, 2023 Apexigen (APGN) stock is rising higher on Wednesday following news of a $16 million acquisition deal with Pyxis Oncology (PYXS). Via InvestorPlace Why Chicken Soup For The Soul Entertainment Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket April 05, 2023 Gainers RiceBran Technologies (NASDAQ: RIBT) gained 43.1% to $1.33 in pre-market trading after gaining 3% on Tuesday. Via Benzinga Why Bullfrog AI Holdings Shares Are Trading Higher By 73%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 04, 2023 Gainers Secoo Holding Limited (NASDAQ: SECO) shares surged 138% to $1.43. Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session April 03, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session March 31, 2023 Via Benzinga Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session March 31, 2023 Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter. Via Benzinga Top 5 Health Care Stocks That May Collapse March 31, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session March 30, 2023 Via Benzinga Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket March 29, 2023 Gainers LogicMark, Inc. (NASDAQ: LGMK) shares rose 36.7% to $0.1914 in pre-market trading after the company reported strong revenue and margin growth for the year ended 2022. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session March 28, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session March 27, 2023 Via Benzinga Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 27, 2023 Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider. Via Benzinga US Stocks Open Higher; Dow Rises 200 Points March 27, 2023 U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Monday. Following the market opening Monday, the Dow traded up 0.64% to 32,443.64 while the NASDAQ rose 0.20% to... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session March 27, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday March 24, 2023 It's time to start off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Friday! Via InvestorPlace Why GameStop Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket March 22, 2023 Gainers Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.